Skip to main content
. 2022 Jan 19;16(1):e0010039. doi: 10.1371/journal.pntd.0010039

Table 1. Demographic and clinical characteristics in the dengue and nondengue groups.

Dengue cohort (N = 13267) Nondengue cohort (N = 53068) χ2 p-value Standardized difference
Sex
 Female 6701 (50.5) 26804 (50.5) -
 Male 6566 (49.5) 26264 (49.5) -
Age (years) 44.4 (18.6) * 44.4 (18.6) * -
 0–17 1279 (9.7) 5116 (9.7) -
 18–35 3055 (23.0) 12220 (23.0) -
 36–50 3436 (25.9) 13744 (25.9) -
 51–64 3616 (27.3) 14464 (27.3) -
 ≥65 1881 (14.2) 7524 (14.2) -
Area of residence
 Tainan 2875 (21.7) 11500 (21.7) -
 Kaohsiung 8668 (65.3) 34672 (65.3) -
 Pingtung 642 (4.8) 2568 (4.8) -
 Others 1082 (8.2) 4328 (8.2) -
Comorbidity
 Hypertension 2759 (20.8) 9778 (18.4) <.0001 0.061
 Diabetes mellitus 1351 (10.2) 4687 (8.8) <.0001 0.047
 Coronary artery disease 1136 (8.6) 3618 (6.8) <.0001 0.067
 COPD 732 (5.5) 2747 (5.2) 0.115 0.015
 Chronic renal disease 334 (2.5) 1207 (2.3) 0.096 0.016
 Liver cirrhosis 65 (0.5) 279 (0.5) 0.608 0.005
 Uncomplicated PUD 1341 (10.1) 4681 (8.8) <.0001 0.045
 Dyslipidemia 1704 (12.8) 5514 (10.4) <.0001 0.079
 Ischemic stroke 280 (2.1) 1128 (2 1) 0.914 0.001
Medication
 Acetylsalicylic acid 829 (6.3) 2598 (4.9) <.0001 0.061
 NSAIDs 7385 (55.7) 24162 (45.5) <.0001 0.204
 Steroids 2010 (15.2) 6804 (12.8) <.0001 0.069
 Thienopyridine 96 (0.7) 284 (0.5) 0.010 0.025
 Dipyridamole 365 (2.8) 1135 (2.1) <.0001 0.041
 Anticoagulants 38 (0.3) 140 (0.3) 0.653 0.004
 SSRIs 142 (1.1) 534 (1.0) 0.511 0.006

Data are expressed in number and percentage, except for the variable “age,” of which the *mean and standard deviation are also shown.

COPD = chronic obstructive pulmonary disease.

NSAIDs = nonsteroidal anti-inflammatory drugs

SSRIs = selective serotonin reuptake inhibitors

PUD = peptie ulcer disease